Michigan Office of Administrative Hearings and Rules  
Administrative Rules Division (ARD)  
611 W. Ottawa Street  
Lansing, MI 48909  
Phone: 517-335-8658 Fax: 517-335-9512  
REQUEST FOR RULEMAKING (RFR)  
1. Department:  
Health and Human Services  
2. Bureau:  
Bureau Of Epidemiology And Population Health  
3. Promulgation type:  
Full Process  
4. Title of proposed rule set:  
Amyotrophic Lateral Sclerosis (ALS) Reporting  
5. Rule numbers or rule set range of numbers:  
R 330.101 - R 330.120  
6. Estimated time frame:  
6 months  
Name of person filling out RFR:  
Mary Brennan  
E-mail of person filling out RFR:  
Phone number of person filling out RFR:  
517-242-9634  
Address of person filling out RFR:  
333 S. Grand Avenue, 5th Floor, Lansing, MI 48909  
7. Describe the general purpose of these rules, including any problems the changes are intended  
to address.  
MCL 24.239  
RFR-Page 2  
These new rules would establish requirements for reporting ALS to the Michigan Department of  
Health and Human Services. ALS is a progressive, degenerative, neurological disease. The onset  
of ALS is typically later in life, peaking between 50 and 75 years of age. The majority of patients  
with ALS die within 2-5 years of diagnosis. In general, it is believed that the ALS incidence is  
2/100,000, so assuming a population size in Michigan of 10 million, that is 200 new cases per  
year; however, the University of Michigan ALS clinic has been seeing more cases and estimates  
300 new cases per year. It is hard to determine the number of missed cases, especially given the  
lack of ALS clinics in Northern Michigan. The state has the authority under the Public Health  
Code to obtain, upon request, medical records to investigate, monitor, prevent, and control  
diseases dangerous to public health. Many of the diseases that are currently reportable to the state  
have treatments or known prevention strategies, but ALS patients and families have nothing that  
makes any significant difference. All ALS patients eventually die. The cost of the care for one  
ALS patient has been estimated at nearly $200,000 per year in some cases, so the prevention of  
the development of ALS in one life in Michigan would have an economic impact. These rules  
would establish a statewide ALS case registry based on data collection of patients with ALS,  
identified by neurologists, hospitals, ALS clinics, and vital records. The ALS case registry would  
provide data for public health surveillance and provide researchers with standardized and  
comprehensive data aimed at identifying risk factors and prevention strategies.  
8. Please cite the specific promulgation authority for the rules (i.e. department director,  
commission, board, etc.).  
The Department Director.  
A. Please list all applicable statutory references (MCLs, Executive Orders, etc.).  
By authority conferred on the department of health and human services by sections 2221, 2226,  
and 2233 of the public health code, 1978 PA 368, MCL 333.2221, 333.2226, and 333.2233, and  
Executive Reorganization Order No. 2015-1, MCL 400.227.  
B. Are the rules mandated by any applicable constitutional or statutory provision? If so, please  
explain.  
The proposed rules are not mandated by any applicable constitutional or statutory provision.  
9. Please describe the extent to which the rules conflict with or duplicate similar rules,  
compliance requirements, or other standards adopted at the state, regional, or federal level.  
The rules do not conflict with or duplicate other rules, compliance requirements, or other  
standards adopted at the state, regional, or federal level.  
10. Is the subject matter of the rules currently contained in any guideline, handbook, manual,  
instructional bulletin, form with instructions, or operational memoranda?  
The subject matter of the proposed rules is contained in guidelines, manuals, forms, and  
operational memoranda.  
11. Are the rules listed on the department’s annual regulatory plan as rules to be processed  
for the current year?  
The rules are listed on the current year annual regulatory plan.  
12. Will the proposed rules be promulgated under Section 44 of the Administrative Procedures  
Act, 1969 PA 306, MCL 24.244, or under the full rulemaking process?  
Full Process  
13. Please describe the extent to which the rules exceed similar regulations, compliance  
requirements, or other standards adopted at the state, regional, or federal level.  
MCL 24.239  
RFR-Page 3  
The rules do not conflict with or duplicate other rules, compliance requirements, or other  
standards adopted at the state, regional, or federal level.  
14. Do the rules incorporate the recommendations received from the public regarding any  
complaints or comments regarding the rules? If yes, please explain.  
Clinicians from the University of Michigan ALS clinic contacted the department and requested the  
development of an ALS case registry and to make ALS a reportable condition. There are currently  
two ALS registries in the United States: 1. National registry that is a passive data system and is  
insufficient for Michigan surveillance and 2. Massachusetts Arego Paul Cellucci Registry, which is  
an active surveillance system based on mandatory reporting of ALS. The U of M team felt that the  
abstraction process detailed in Massachusetts is sufficient and collects appropriate secondary data  
use elements. The elements collected in Massachusetts allow determination of the number of ALS  
cases in the state, identify any gaps in care, identify underserved areas, assess for hotspots, and  
understand if the number of cases are increasing over time (which is what U of M is seeing in their  
clinics). The U of M team has stressed the importance of making ALS reportable to their patients  
and their families. In addition, the ALS registry and reporting has the full support of all 4 ALS  
clinics and their staff in Michigan.  
15. If amending an existing rule set, please provide the date of the last evaluation of the rules  
and the degree, if any, to which technology, economic conditions, or other factors have changed  
the regulatory activity covered by the rules since the last evaluation.  
This is a new rule set.  
16. Are there any changes or developments since implementation that demonstrate there is no  
continued need for the rules, or any portion of the rules?  
This is a new rule set.  
17. Is there an applicable decision record (as defined in MCL 24.203(6) and required by MCL  
24.239(2))? If so, please attach the decision record.  
No  
MCL 24.239  
;